CHEK2 and cyclic hematopoiesis: A separate analysis of a smaller dataset from the UK Biobank revealed that the c.100delC germline CHEK2 variant confers a markedly increased risk of DNMT3A-CH with the effect size 4 times larger than that of the other common risk alleles such as ATM, TERT, or SCM4 [1].